Pharming Group N.V. (PHAR) shareholders
Close on Nov 13, 2026Market cap $884.12MP/E 315.0Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PHAR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| MAC Alpha Capital Management, LP | 2,148,144 | 0.31% | $2.95M | New | 1.36% |
| Silverberg Bernstein Capital Management LLC | 41,547 | 0.01% | $577.09K | −3,200 | 0.22% |
| Crossmark Global Holdings, Inc. | 12,463 | 0.00% | $169.00K | New | 0.00% |
| Citadel Advisors LLC | 11,972 | 0.00% | $162.34K | +1,783 | 0.00% |
| Morgan Stanley | 11,500 | 0.00% | $159.74K | +11 | 0.00% |
| SmartHarvest Portfolios, LLC | 10,415 | 0.00% | $144.66K | −382 | 0.05% |
| Knoll Capital Management, LLC | 4,091 | 0.00% | $56.82K | +34 | 0.03% |
| Silver Grove Financial Group, Inc. | 1,071 | 0.00% | $14.88K | New | 0.01% |
| Nalls Sherbakoff Group, LLC | 870 | 0.00% | $12.08K | – | 0.01% |
| Global Retirement Partners, LLC | 456 | 0.00% | $6.33K | New | 0.00% |
| Integrated Wealth Concepts LLC | 380 | 0.00% | $5.28K | New | 0.00% |
| Optiver Holding B.V. | 305 | 0.00% | $4.14K | New | 0.00% |
| Bnp Paribas Arbitrage, Snc | 300 | 0.00% | $4.17K | −100 | 0.00% |
| NewEdge Advisors, LLC | 187 | 0.00% | $2.60K | −1,963 | 0.00% |
| UBS Group AG | 39 | 0.00% | $542 | New | 0.00% |
| Osaic Holdings, Inc. | 16 | 0.00% | $222 | −112 | 0.00% |
| Larson Financial Group LLC | 7 | 0.00% | $97 | −336 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | 0.00% | $14 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 18 | 2M | 0.3% | 8 / 3 | 6 / 3 | 2M | 0M |
| Q1 2026 | 13 | 0M | 0.0% | 5 / 1 | 6 / 3 | 0M | 0M |
| Q4 2025 | 11 | 0M | 0.0% | 4 / 3 | 2 / 2 | 0M | 0M |
| Q3 2025 | 9 | 0M | 0.0% | 5 / 1 | 1 / 0 | 0M | 0M |
| Q2 2025 | 4 | 0M | 0.0% | 1 / 1 | 0 / 1 | 0M | 0M |
| Q1 2025 | 4 | 0M | 0.0% | 2 / 1 | 0 / 3 | 0M | 0M |
| Q4 2024 | 5 | 0M | 0.0% | 2 / 1 | 1 / 1 | 0M | 0M |
| Q3 2024 | 4 | 0M | 0.0% | 2 / 2 | 0 / 2 | 0M | 0M |
| Q2 2024 | 4 | 0M | 0.0% | 1 / 2 | 1 / 0 | 0M | 0M |
| Q1 2024 | 3 | 0M | 0.0% | 1 / 1 | 0 / 0 | 0M | 0M |
| Q4 2023 | 2 | 0M | 0.0% | 1 / 1 | 0 / 2 | 0M | 0M |
| Q3 2023 | 3 | 0M | 0.0% | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
2 funds held PHAR in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PHAR | Value | % of fund | As of |
|---|---|---|---|---|---|
| Steward Values Enhanced International Fund | 12,463 | 0.00% | $125.63K | 0.04% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 2,093 | 0.00% | $27.19K | 0.00% | May 31, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Pharming's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,855 shares on Aug 17, 2026 over the last 90 days.
See a number that looks wrong?